Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets) Meeting Abstract
| Authors: | Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; Wolchok, J. D.; Berger, M. F.; Solit, D. B.; Chapman, P. B. |
| Abstract Title: | Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets) |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419602761 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.9060 |
| Notes: | Meeting Abstract: 9060 -- Source: Wos |
